FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1972626157> ?p ?o ?g. }

• W1972626157 endingPage "1420" @default.
• W1972626157 startingPage "1415" @default.
• W1972626157 abstract "Although current literature demonstrates metabolic abnormalities are associated with mortality, obese patients who tend to have more metabolic abnormalities paradoxically have lower overall mortality rates compared to their normal-weight counterparts. In this study, we examined the prevalence of metabolic abnormality clustering and its relation to mortality in obese and normal-weight patients after percutaneous coronary intervention (PCI). Patients (n = 9,673) undergoing elective PCI from October 2003 through December 2006 at a single urban hospital were categorized by body mass index (BMI) levels of 18.5 to 24.9, 25.0 to 29.9, 30.0 to 34.9, and ≥35 kg/m2 and by number of metabolic abnormalities possessed (hypertension, impaired fasting glucose/diabetes, triglycerides ≥150 mg/dl, high-density lipoprotein cholesterol < 40 mg/dl, and C-reactive protein ≥2.0 mg/L). All-cause mortality was assessed through June 30, 2007. Mean age of patients was 65.9 years and 66% were men. Prevalences of 4 or 5 metabolic abnormalities were 12%, 18%, 24%, and 31% in patients with BMI levels of 18.5 to 24.9, 25.0 to 29.9, 30 to 34.9, and ≥35 kg/m2, respectively. In patients with BMI of 30.0 to 34.9 kg/m2, hazard ratios (95% confidence intervals) for mortality associated with 2, 3, and 4 to 5 metabolic abnormalities versus 0 to 1 metabolic abnormality were 1.31 (0.79 to 2.17), 1.42 (0.83 to 2.43), and 2.39 (1.24 to 4.59), respectively. Analogous hazard ratios for patients with BMI ≥35 kg/m2 were 1.94 (0.90 to 4.20), 1.44 (0.63 to 3.28), and 2.17 (0.91 to 5.18). All-cause mortality rates per 1,000 person-years were 55.5, 33.7, 28.3, and 33.8 in patients with BMI levels of 18.5 to 24.9, 25 to 29.9, 30 to 34.9, and ≥35 kg/m2, respectively. In conclusion, BMI levels of 25.0 to 29.9 and 30 to 34.9 kg/m2 were associated with lower all-cause mortality after PCI. However, an increased number of metabolic abnormalities translated into increased all-cause mortality. Although current literature demonstrates metabolic abnormalities are associated with mortality, obese patients who tend to have more metabolic abnormalities paradoxically have lower overall mortality rates compared to their normal-weight counterparts. In this study, we examined the prevalence of metabolic abnormality clustering and its relation to mortality in obese and normal-weight patients after percutaneous coronary intervention (PCI). Patients (n = 9,673) undergoing elective PCI from October 2003 through December 2006 at a single urban hospital were categorized by body mass index (BMI) levels of 18.5 to 24.9, 25.0 to 29.9, 30.0 to 34.9, and ≥35 kg/m2 and by number of metabolic abnormalities possessed (hypertension, impaired fasting glucose/diabetes, triglycerides ≥150 mg/dl, high-density lipoprotein cholesterol < 40 mg/dl, and C-reactive protein ≥2.0 mg/L). All-cause mortality was assessed through June 30, 2007. Mean age of patients was 65.9 years and 66% were men. Prevalences of 4 or 5 metabolic abnormalities were 12%, 18%, 24%, and 31% in patients with BMI levels of 18.5 to 24.9, 25.0 to 29.9, 30 to 34.9, and ≥35 kg/m2, respectively. In patients with BMI of 30.0 to 34.9 kg/m2, hazard ratios (95% confidence intervals) for mortality associated with 2, 3, and 4 to 5 metabolic abnormalities versus 0 to 1 metabolic abnormality were 1.31 (0.79 to 2.17), 1.42 (0.83 to 2.43), and 2.39 (1.24 to 4.59), respectively. Analogous hazard ratios for patients with BMI ≥35 kg/m2 were 1.94 (0.90 to 4.20), 1.44 (0.63 to 3.28), and 2.17 (0.91 to 5.18). All-cause mortality rates per 1,000 person-years were 55.5, 33.7, 28.3, and 33.8 in patients with BMI levels of 18.5 to 24.9, 25 to 29.9, 30 to 34.9, and ≥35 kg/m2, respectively. In conclusion, BMI levels of 25.0 to 29.9 and 30 to 34.9 kg/m2 were associated with lower all-cause mortality after PCI. However, an increased number of metabolic abnormalities translated into increased all-cause mortality." @default.
• W1972626157 created "2016-06-24" @default.
• W1972626157 creator A5002336422 @default.
• W1972626157 creator A5006697068 @default.
• W1972626157 creator A5006907107 @default.
• W1972626157 creator A5009530321 @default.
• W1972626157 creator A5030108485 @default.
• W1972626157 creator A5037957452 @default.
• W1972626157 creator A5038203776 @default.
• W1972626157 creator A5038592676 @default.
• W1972626157 creator A5043621364 @default.
• W1972626157 creator A5079959622 @default.
• W1972626157 creator A5081501369 @default.
• W1972626157 creator A5084909260 @default.
• W1972626157 date "2011-05-01" @default.
• W1972626157 modified "2023-10-16" @default.
• W1972626157 title "Clustering of Metabolic Abnormalities Among Obese Patients and Mortality After Percutaneous Coronary Intervention" @default.
• W1972626157 cites W1535035449 @default.
• W1972626157 cites W1562487551 @default.
• W1972626157 cites W1598667444 @default.
• W1972626157 cites W171809150 @default.
• W1972626157 cites W1967299404 @default.
• W1972626157 cites W1992748772 @default.
• W1972626157 cites W1998804369 @default.
• W1972626157 cites W2008113677 @default.
• W1972626157 cites W2017221955 @default.
• W1972626157 cites W2030114967 @default.
• W1972626157 cites W2039663806 @default.
• W1972626157 cites W2044404335 @default.
• W1972626157 cites W2046211210 @default.
• W1972626157 cites W2050289032 @default.
• W1972626157 cites W2066890285 @default.
• W1972626157 cites W2074212638 @default.
• W1972626157 cites W2076992606 @default.
• W1972626157 cites W2098059712 @default.
• W1972626157 cites W2098885552 @default.
• W1972626157 cites W2100234224 @default.
• W1972626157 cites W2105025016 @default.
• W1972626157 cites W2118667643 @default.
• W1972626157 cites W2124665258 @default.
• W1972626157 cites W2127835340 @default.
• W1972626157 cites W2129413693 @default.
• W1972626157 cites W2145942481 @default.
• W1972626157 cites W2153089743 @default.
• W1972626157 cites W2172144525 @default.
• W1972626157 cites W71404102 @default.
• W1972626157 doi "https://doi.org/10.1016/j.amjcard.2011.01.012" @default.
• W1972626157 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21420054" @default.
• W1972626157 hasPublicationYear "2011" @default.
• W1972626157 type Work @default.
• W1972626157 sameAs 1972626157 @default.
• W1972626157 citedByCount "6" @default.
• W1972626157 countsByYear W19726261572013 @default.
• W1972626157 countsByYear W19726261572014 @default.
• W1972626157 countsByYear W19726261572015 @default.
• W1972626157 countsByYear W19726261572016 @default.
• W1972626157 countsByYear W19726261572017 @default.
• W1972626157 countsByYear W19726261572020 @default.
• W1972626157 crossrefType "journal-article" @default.
• W1972626157 hasAuthorship W1972626157A5002336422 @default.
• W1972626157 hasAuthorship W1972626157A5006697068 @default.
• W1972626157 hasAuthorship W1972626157A5006907107 @default.
• W1972626157 hasAuthorship W1972626157A5009530321 @default.
• W1972626157 hasAuthorship W1972626157A5030108485 @default.
• W1972626157 hasAuthorship W1972626157A5037957452 @default.
• W1972626157 hasAuthorship W1972626157A5038203776 @default.
• W1972626157 hasAuthorship W1972626157A5038592676 @default.
• W1972626157 hasAuthorship W1972626157A5043621364 @default.
• W1972626157 hasAuthorship W1972626157A5079959622 @default.
• W1972626157 hasAuthorship W1972626157A5081501369 @default.
• W1972626157 hasAuthorship W1972626157A5084909260 @default.
• W1972626157 hasConcept C126322002 @default.
• W1972626157 hasConcept C134018914 @default.
• W1972626157 hasConcept C164705383 @default.
• W1972626157 hasConcept C207103383 @default.
• W1972626157 hasConcept C2780221984 @default.
• W1972626157 hasConcept C2780400711 @default.
• W1972626157 hasConcept C44249647 @default.
• W1972626157 hasConcept C45393284 @default.
• W1972626157 hasConcept C500558357 @default.
• W1972626157 hasConcept C50382708 @default.
• W1972626157 hasConcept C511355011 @default.
• W1972626157 hasConcept C555293320 @default.
• W1972626157 hasConcept C71924100 @default.
• W1972626157 hasConcept C90924648 @default.
• W1972626157 hasConceptScore W1972626157C126322002 @default.
• W1972626157 hasConceptScore W1972626157C134018914 @default.
• W1972626157 hasConceptScore W1972626157C164705383 @default.
• W1972626157 hasConceptScore W1972626157C207103383 @default.
• W1972626157 hasConceptScore W1972626157C2780221984 @default.
• W1972626157 hasConceptScore W1972626157C2780400711 @default.
• W1972626157 hasConceptScore W1972626157C44249647 @default.
• W1972626157 hasConceptScore W1972626157C45393284 @default.
• W1972626157 hasConceptScore W1972626157C500558357 @default.
• W1972626157 hasConceptScore W1972626157C50382708 @default.
• W1972626157 hasConceptScore W1972626157C511355011 @default.
• W1972626157 hasConceptScore W1972626157C555293320 @default.
• W1972626157 hasConceptScore W1972626157C71924100 @default.

• next